NCT Number: NCT02703948
Injection Technique Assessment of Restylane Silk With Lidocaine for Lip Augmentation
This is a multi-center, open-label, single-arm study to assess the safety of an injection technique with Restylane Silk in lip augmentation and correction of perioral rhytids .
Looking for future studies?
Notify MeKey information
Age range
22 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Primary location
United States, California, Beverly Hills, California, United States
Who can participate
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Subjects willing to comply with the requirements of the study and providing written informed consent including release of copyright of photography images.
- Males or females, 22 years of age or older
- Subjects seeking augmentation therapy for the lips.
Exclusion criteria
- History of allergy or hypersensitivity to injectable HA gel or to gram positive bacterial proteins.
- History of allergy or hypersensitivity to lidocaine, other amide type anesthetics, or topical anesthetics or nerve blocking agents
- Previous surgery to the upper or lower lip, lip piercing or tattoo, or history of facial trauma.
Treatment and study plan
Primary outcomes
-
Number of Participants With Adverse Events With the Use of Restylane Silk With Lidocaine
Time frame: 12 weeks
Sponsors and collaborators
Lead sponsor
Galderma R&D
Industry
Registry information
Important dates
- Study start
- 2016
- Primary completion
- 2016
- Study completion
- 2016
- First posted
- Mar 9, 2016
- Registry last updated
- Aug 26, 2022
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Evaluation of Performance and Safety of Injectable KIO017 Device Range for Facial Tissue Filling
NCT06872359
Cheek Augmentation, Contouring
Aix-en-Provence, France
View Trial DetailsPerformance and Safety of Semical Dermal Fillers in Facial Rejuvenation
NCT07160777
Facial Aging, Facial Wrinkles and Rhytides Reduction
Antalya, Turkey (Türkiye)
View Trial Details